Drugs / Sidarbenamide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06902038 | Mar → Dec 2025 overdue | HIV infectious disease | Jun Chen, MD | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sidarbenamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06902038 ↗ |
| Route | Oral | “Sidarbenamide 10mg biw orally for 2 weeks” NCT06902038 ↗ |